Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.

Recs

0

Why Optimer Pharmaceuticals Shares Popped

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of biotechnology company Optimer Pharmaceuticals (UNKNOWN: OPTR.DL  ) climbed 13% today after preliminary 2012 sales for its diarrhea drug Dificid impressed Wall Street.

So what: The stock has slumped in recent months on concerns over sluggish Dificid sales, but today's preliminary 2012 numbers -- sales in the U.S. and Canada totaling $74.4 million versus $21.3 million in the year-ago period -- suggest that management's turnaround initiatives are taking hold. In October, Optimer announced a 25% price cut on Dificid to help boost its adoption rate, and it looks like hospitals are indeed biting.

Now what: Expect the positive sales momentum to continue. "We believe the early response to our new strategy is very encouraging," President and CEO Pedro Lichtinger said in a statement. "We are particularly encouraged by increased DIFICID use in hospitals that our sales force is targeting, and by the number of hospitals that are initiating a review of DIFICID's formulary position."

So while Optimer remains too speculative for this Fool, more aggressive growth seekers might want to take a closer look.

What's inside Supernova?
If you're an investor looking for big long-term winners, Motley Fool co-founder David Gardner's picks have frequently trounced the market. How? Because he's always on the lookout for revolutionary stocks and recommends them before Wall Street catches on to their disruptive potential. If you're interested in how David discovers his winners, click here to get instant access to a personal tour behind David's Supernova service.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2182787, ~/Articles/ArticleHandler.aspx, 8/5/2015 8:32:29 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Brian Pacampara
TMFEZMagic

I take a look at big 10% moves, as well as stock-shaking analyst calls, on a daily basis for The Fool. While I don't believe in active trading, closely monitoring Mr. Market's mood swings can help identify long-term opportunities.

Today's Market

updated 11 hours ago Sponsored by:
DOW 17,550.69 -47.51 -0.27%
S&P 500 2,093.32 -4.72 -0.22%
NASD 5,105.55 -9.84 -0.19%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
OPTR.DL $0.00 Down +0.00 +0.00%
Optimer Pharmaceut… CAPS Rating: *

Advertisement